In August, US Secretary of Health and Human Services Robert F. Kennedy Jr. announced the suspension of 22 mRNA vaccine development contracts, representing nearly $500 million in public funds. This decision, announced in an official statement widely shared on social media, marks a major shift in American vaccination policy and reflects Kennedy's long-standing criticism of this technology.
A decision based on scientific criticism
According to the official statement, this decision is based on a thorough analysis of scientific data and consultations with experts. Kennedy stated that mRNA vaccines do not effectively protect against upper respiratory tract infections, such as COVID-19 and influenza, because they only encode a small portion of viral proteins.
The Health Secretary also emphasized that a single viral mutation could render these vaccines ineffective, a claim echoed by some vaccinologists who have expressed similar concerns for years. He went even further, suggesting that mRNA vaccines may have contributed to prolonging the COVID-19 pandemic by promoting the emergence of new viral mutations. According to him, vaccinating during a pandemic would create an environment conducive to the replication of even more infectious variants, which would pose more risks than benefits for respiratory viruses.
The Biomedical Advanced Research and Development Authority (BARDA) will therefore end investments in these 22 projects, in order to free up funds to finance vaccine platforms deemed safer and more effective.
A context of questioning mRNA vaccines
This decision is part of a series of measures taken by Kennedy since taking office. Known for his long-standing skepticism toward certain vaccination policies and for repeatedly demanding robust scientific evidence, he has already withdrawn recommendations for COVID-19 vaccination for healthy children and pregnant women. He has also replaced the CDC's advisory committee on immunizations with members who share his views.
This announcement represents a major blow to the biomedical sector, which had hoped to extend the use of mRNA to many other diseases. He clarified, however, that this decision did not constitute a complete rejection of mRNA technology, but rather limited its application to respiratory viruses. He promised to refocus on alternatives such as whole-virus vaccines or other innovative platforms, but the details of these solutions remain unclear for now.
Polarized reactions
This news has sparked mixed reactions. Kennedy supporters hailed it as a victory against a technology they considered risky and pointed out that dissenting voices had been censored in the past for raising these concerns. Some former healthcare professionals claim they were banned from social media for sharing similar information.
However, medical experts and public health organizations are expressing deep concern. While some analyzes question the benefits of mRNA vaccines, many specialists still believe that these vaccines, developed rapidly during the pandemic thanks to initiatives like Operation Warp Speed, saved millions of lives by reducing the severity of infections. According to some medical commentators, abandoning this technology would leave the country vulnerable to future pandemics.
Others, however, point out that viral mutations occur independently of vaccination. Nevertheless, the evidence presented by these individuals sometimes comes from scientific sources linked to the pharmaceutical industry, some of which are even under investigation by the US Department of Justice.
An overhaul of public health policy
This decision is part of a broader transformation of American health policy under Kennedy, who spearheaded the Make America Healthy Again (MAHA) program. Previous measures included ending funding for research on vaccine hesitancy and terminating contracts with companies like Moderna for the production of avian flu vaccines.
Kennedy's detractors accuse him of prioritizing his own ideologies over established science, while his supporters see it as a necessary reassessment of current practices. The Department of Health and Human Services maintains that this shift aims to favor platforms with stronger safety records.
The lack of concrete details on the proposed alternatives opens the door to criticism, which sees uncertainty regarding the future strategy of the United States in the face of health threats, without however examining the facts.
Robert F. Kennedy Jr.'s decision to halt $500 million in mRNA vaccine research projects marks a controversial turning point in American health policy. While the decision pleases its supporters and those who question mRNA technology, it worries experts, as it could compromise preparedness for future pandemics. Amid growing polarization around the vaccine issue, all eyes are now on Washington to see how this overhaul will play out in the coming months.
0 Comment:
Post a Comment